$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Human hematopoietic stem cell 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12N-005/00
  • C12Q-001/00
  • G01N-033/53
출원번호 US-0502616 (1990-03-30)
발명자 / 주소
  • Tsukamoto Ann (Palo Alto CA) Baum Charles M. (Menlo Park CA) Aihara Yukoh (Hiratsuka CA JPX) Weissman Irving (Palo Alto CA)
출원인 / 주소
  • SyStemix, Inc. (Palo Alto CA 02)
인용정보 피인용 횟수 : 268  인용 특허 : 0

초록

Human hematopoietic stem cells are provided by separation of the stem cells from dedicated cells. The stem cells may than be maintained by regeneration in an appropriate growth medium. Means are provided for assaying for the stem cells as to their capability for producing members of each of the hema

대표청구항

A cellular composition comprising human hematopoietic stem cells with fewer than 5% of lineage committed cells, wherein said hematopoietic stem cells are characterized as Thy-1+, capable of self-regeneration in a coculture medium and differentiation to members of the lymphoid and myelomonocytic hema

이 특허를 인용한 특허 (268)

  1. Hwu, Patrick; Kershaw, Michael H.; Rosenberg, Steven A., Activated dual specificity lymphocytes and their methods of use.
  2. Kopen, Gene; Wagner, Joseph; Ragaglia, Vanessa; Heimbach, Baron; Gore, Richard S., Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders.
  3. Gammelsaeter, Runhild; Remmereit, Jan, Administration of cells and cellular extracts for rejuvenation.
  4. Gammelsaeter, Runhild; Remmereit, Jan, Administration of cells and cellular extracts for rejuvenation.
  5. Gammelsaeter, Runhild; Remmereit, Jan, Administration of cells and cellular extracts for rejuvenation.
  6. Jaffe, Eileen K., Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules.
  7. Jaffe, Eileen K., Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules.
  8. Wong, Chi-Huey; Wu, Chung-Yi, Anti-HER2 glycoantibodies and uses thereof.
  9. Bartelmez, Stephen H.; Sitnicka, Ewa; Ruscetti, Frank, Anti-transforming growth factor Beta (TGF-β) treated stem cell composition and method.
  10. Gurney, Austin L.; Sato, Aaron Ken; Axelrod, Fumiko Takada; Hoey, Timothy Charles; Satyal, Sanjeev H.; Mitra, Satyajit Sujit Kumar, Antibodies against human FZD5 and FZD8.
  11. Wu, Yan; Bohlen, Peter; Hicklin, Daniel J., Antibodies against vascular endothelial growth factor receptor-1.
  12. Wu, Yan; Hicklin, Danny J.; Bohlen, Peter, Antibodies against vascular endothelial growth factor receptor-1.
  13. Lawman Michael J. P. ; Lawman Patricia, Antibody recognizing a small subset of human hematopoietic cells.
  14. Lawman, Michael J. P.; Lawman, Patricia, Antibody recognizing a small subset of human hematopoietic cells.
  15. Lawman, Michael J. P.; Lawman, Patricia, Antibody recognizing a small subset of human hematopoietic cells.
  16. Lawman,Michael J. P.; Lawman,Patricia, Antibody recognizing a small subset of human hematopoietic cells.
  17. Michael J. P. Lawman ; Patricia Lawman, Antibody recognizing a small subset of human hematopoietic cells.
  18. Lawman Michael J. P. ; Lawman Patricia, Antigen found on a small subset of human hematopoietic cells which binds to monoclonal antibody MG1.
  19. Sindhi, Rakesh; AshokKumar, Chethan, Antigen presenting cell assay.
  20. Sindhi, Rakesh; AshokKumar, Chethan, Antigen presenting cell assay.
  21. Furcht, Leo T.; Verfaillie, Catherine M.; Reyes, Morayma, Assay utilizing multipotent adult stem cells.
  22. Sindhi, Rakesh; AshokKumar, Chethan, B-cell antigen presenting cell assay.
  23. Sindhi, Rakesh; Ashokkumar, Chethan, B-cell antigen presenting cell assay.
  24. Sindhi, Rakesh; Ashokkumar, Chethan, B-cell antigen presenting cell assay.
  25. Gallo, Robert C.; Bryant, Joseph; Lundardi-Iskandar, Yanto, Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA).
  26. Yin, Peng; Pierce, Niles A., Biomolecular self-assembly.
  27. Long Michael W. ; Mann Kenneth G., Bone precursor cells: compositions and methods.
  28. Long, Michael W.; Mann, Kenneth G., Bone precursor cells: compositions and methods.
  29. Long,Michael W.; Mann,Kenneth G., Bone precursor cells: compositions and methods.
  30. Quesenberry Peter J., Cell compositions for use in transplantation.
  31. Ho, Tony W.; Kopen, Gene C.; Righter, William F.; Rutkowski, J. Lynn; Wagner, Joseph, Cell populations which co-express CD49c and CD90.
  32. Ho, Tony W.; Kopen, Gene C.; Righter, William F.; Rutkowski, J. Lynn; Wagner, Joseph, Cell populations which co-express CD49c and CD90.
  33. Ho, Tony W.; Kopen, Gene C.; Righter, William F.; Rutkowski, J. Lynn; Wagner, Joseph; Herring, W. Joseph; Ragaglia, Vanessa, Cell populations which co-express CD49c and CD90.
  34. Wong, Chi-Huey; Fang, Jim-Min; Cheng, Yih-Shyun E.; Tsai, Chamg-Sheng, Cell-permeable probes for identification and imaging of sialidases.
  35. Gammelsaeter, Runhild; Remmereit, Jan, Cellular extracts.
  36. Gammelsaeter, Runhild; Remmereit, Jan, Cellular extracts.
  37. Gammelsaeter, Runhild; Remmereit, Jan, Cellular extracts.
  38. Ahrens, Eric T.; Srinivas, Mangala, Cellular labeling and quantification for nuclear magnetic resonance techniques.
  39. Ahrens, Eric T., Cellular labeling for nuclear magnetic resonance techniques.
  40. Ahrens, Eric T., Cellular labeling for nuclear magnetic resonance techniques.
  41. Alikani, Mina; Willadsen, Steen Malte, Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos.
  42. Makoto Kikuchi JP; Shinya Ikematsu JP; Munehiro Oda JP; Sadatoshi Sakuma JP; Takashi Muramatsu JP, Composition comprising midkine or pleiotrophin protein and method of increasing hematopoietic cells.
  43. Bjornson, Christopher R.; Rietze, Rod L.; Reynolds, Brent A.; Vescovi, Angelo L., Composition comprising multipotent neural stem cells for generation of hematopoietic cells.
  44. Hubel,Allison, Compositions and methods for cryopreservation of peripheral blood lymphocytes.
  45. Gurney, Austin; Lewicki, John; Satyal, Sanjeev; Hoey, Timothy, Compositions and methods for diagnosing and treating cancer.
  46. Janjic, Jelena; Ahrens, Eric T., Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques.
  47. Clarke, Michael F.; Hoey, Tim; Wang, Xinhao; Dylla, Scott; Gurney, Austin; Dalerba, Piero; Prince, Mark; Chen, Grace, Compositions and methods for treating and diagnosing cancer.
  48. Simeone, Diane M.; Clarke, Michael F., Compositions and methods for treating and diagnosing pancreatic cancer.
  49. Simeone, Diane M.; Clarke, Michael F., Compositions and methods for treating and diagnosing pancreatic cancer.
  50. Wong, Chi-Huey; Hsu, Tsui-Ling; Lou, Yi-Wei; Lin, Chih-Wei; Yeh, Shih-Chi; Wu, Chung-Yi; Wu, Han-Chung, Compositions and methods for treatment and detection of cancers.
  51. Wong, Chi-Huey; Hsu, Tsui-Ling; Lou, Yi-Wei; Lin, Chih-Wei; Yeh, Shih-Chi; Wu, Chung-Yi; Wu, Han-Chung, Compositions and methods for treatment and detection of cancers.
  52. Wong, Chi-Huey; Hsu, Tsui-Ling; Lou, Yi-Wei; Lin, Chih-Wei; Yeh, Shih-Chi; Wu, Chung-Yi; Wu, Han-Chung, Compositions and methods for treatment and detection of cancers.
  53. Wong, Chi-Huey; Wu, Chung-Yi; Ma, Che, Compositions and methods relating to universal glycoforms for enhanced antibody efficacy.
  54. Wong, Chi-Huey; Wu, Chung-Yi; Ma, Che; Wu, Han-Chung, Compositions and methods relating to universal glycoforms for enhanced antibody efficacy.
  55. Shroff, Geeta, Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation.
  56. Shroff, Geeta, Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation.
  57. Shroff, Geeta, Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation.
  58. Makarovskiy, Andrew N., Compositions for identification and isolation of stem cells.
  59. Makarovskiy,Andrew N., Compositions for identification and isolation of stem cells.
  60. Kraus Morey (Worcester MA) Friberg Jill (Worcester MA), Continuous selective clonogenic expansion of relatively undifferentiated cells.
  61. Clarke, Michael F.; Dylla, Scott J.; Satyal, Sanjeev, Determining the capability of a test compound to affect solid tumor stem cells.
  62. Clarke, Michael F.; Dylla, Scott J.; Satyal, Sanjeev, Determining the capability of a test compound to affect solid tumor stem cells.
  63. Palsson Bernhard O. ; Emerson Stephen G. ; Schwartz Richard M., Devices for maintaining and growing human stem and/or hematopoietics cells.
  64. Gearhart, John D.; Shamblott, Michael Joseph, Differentiation of human embryonic germ cells.
  65. Verfaillie, Catherine; Chase, Lucas, Endodermal progenitor cells.
  66. Weiss, Ron; Lemischka, Ihor; Purnick, Priscilla E. M.; Schaniel, Christoph; Miller, Miles; Guye, Patrick, Engineered cellular pathways for programmed autoregulation of differentiation.
  67. Weiss, Ron; Lemischka, Ihor; Purnick, Priscilla; Schaniel, Christoph; Miller, Miles; Guye, Patrick, Engineered cellular pathways for programmed autoregulation of differentiation.
  68. Wong, Chi-Huey; Fang, Jim-Min; Liu, Kung-Cheng; Jan, Jia-Tsrong; Cheng, Yih-Shyun E.; Cheng, Ting-Jen R., Enhanced anti-influenza agents conjugated with anti-inflammatory activity.
  69. Caplan Arnold I. ; Haynesworth Stephen E. ; Gerson Stanton L. ; Lazarus Hillard M., Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells.
  70. Zhang, ChengCheng; Lodish, Harvey, Ex vivo expansion of human hematopoietic stem cells.
  71. Kikuchi, Makoto; Ikematsu, Shinya; Oda, Munehiro; Sakuma, Sadatoshi; Muramatsu, Takashi, Expansion of hematopoietic cells using midkine or pleiotrophin.
  72. Hoffman Ronald ; Brandt John, Expansion of human hematopoietic progenitor cells in a liquid medium.
  73. Chang Chia-Cheng ; Trosko James, Expression of estrogen receptors in type I and type II human breast epithelial cells.
  74. Vacanti, Joseph P.; Shin, Young-Moon Michael; Ogilvie, Jennifer; Sevy, Alexander; Maemura, Tomoyuki; Ishii, Osamu; Kaazempur-Mofrad, Mohammad Reza; Borenstein, Jeffrey T.; King, Kevin R.; Wang, Chiao-Chun; Weinberg, Eli, Fabrication of vascularized tissue using microfabricated two-dimensional molds.
  75. Gurney, Austin L., Frizzled-binding agents and their use in screening for WNT inhibitors.
  76. Gurney, Austin L., Frizzled-binding agents and uses thereof.
  77. Bjornson Christopher R. ; Rietze Rod L.,AUX ; Reynolds Brent A.,CAX ; Vescovi Angelo L.,ITX, Generation of hematopoietic cells from multipotent neural stem cells.
  78. Bjornson,Christopher R.; Rietze,Rod L.; Reynolds,Brent A.; Vescovi,Angelo L., Generation of hematopoietic cells from multipotent neural stem cells.
  79. Wong, Chi-Huey; Wu, Chung-Yi; Wang, Chia-Hung; Li, Shiou-Ting, Glycan conjugates and use thereof.
  80. David Bellamy ; Ludwig Wolf, Jr., Heat and pressure-formed flexible containers.
  81. Daley, John P.; Dadey, Barbara M.; Biddle, William C.; Wysocki, Michelle G., Hematopoietic cell culture nutrient supplement.
  82. Ildstad Suzanne T. ; Simmons Richard L. ; Ricordi Camillo ; Wren Sherry M. ; Kaufman Christina, Hematopoietic facilitatory cells and their uses.
  83. Yilmaz, Omer H.; Kiel, Mark J.; Morrison, Sean; Iwashita, Toshihide, Hematopoietic stem cell identification and isolation.
  84. Yilmaz,Omer H.; Kiel,Mark J.; Morrison,Sean; Iwashita,Toshihide, Hematopoietic stem cell identification and isolation.
  85. Smith, Clayton A.; Storms, Robert W.; Gilboa, Eli, Hematopoietic stem cells.
  86. Reid Lola M. ; Sigal Samuel H. ; Brill Shlomo,ILX ; Holst Patricia A., Hepatic progenitors and method of isolating same.
  87. Lyman, Stewart D.; Beckmann, Patricia M., Human FLTS3 ligand.
  88. Zhu,Zhenping, Human antibodies specific to KDR and uses thereof.
  89. Chang Chia-Cheng (Okemos MI) Trosko James E. (Okemos MI), Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics.
  90. Gearhart John D. ; Shamblott Michael Joseph, Human embryonic germ cell line and methods of use.
  91. Gearhart John D. ; Shamblott Michael Joseph, Human embryonic pluripotent germ cells.
  92. Gearhart John D. ; Shamblott Michael Joseph, Human enbryonic germ cell and methods of use.
  93. Ildstad, Suzanne T.; Elliott, Mary Jane, Human facilitating cells.
  94. Ildstad, Suzanne T.; Elliott, Mary Jane, Human facilitating cells.
  95. Gurney, Austin L.; Lewicki, John; Satyal, Sanjeev; Hoey, Timothy, Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cells.
  96. Hoffman Ronald ; Brandt John, Human hematopoietic progenitor cell preparations and their expansion in a liquid medium.
  97. Amy H. Yin ; Sheri Miraglia ; Wayne G. Godfry ; David W. Buck, Human hematopoietic stem and progenitor cell antigen.
  98. Tsukamoto Ann ; Baum Charles M. ; Aihara Yukoh,JPX ; Weissman Irving, Human hematopoietic stem cell.
  99. Tsukamoto Ann ; Baum Charles M. ; Aihara Yukoh,JPX ; Weissman Irving, Human hematopoietic stem cell.
  100. Wong, Chi-Huey; Yu, Alice L.; Lin, Kun-Hsien; Wu, Tai-Na, Human iNKT cell activation using glycolipids.
  101. Wong, Chi-Huey; Yu, Alice L.; Lin, Kun-Hsien; Wu, Tai-Na, Human iNKT cell activation using glycolipids with altered glycosyl groups.
  102. Smith, Alan K.; Smith, Douglas M.; Mandalam, Ramkumar K., Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses.
  103. Chiu, Wei-Chun; Chou, Min-Yuan, Humanized anti-human CD34 monoclonal antibody and uses thereof.
  104. Dirks, Robert; Pierce, Niles A., Hybridization chain reaction.
  105. Dirks, Robert; Pierce, Niles A., Hybridization chain reaction.
  106. Pierce, Niles A.; Dirks, Robert; Fraser, Scott E., Hybridization chain reaction amplification for in situ imaging.
  107. Pierce, Niles A.; Dirks, Robert; Fraser, Scott E., Hybridization chain reaction amplification for in situ imaging.
  108. Pierce, Niles A.; Dirks, Robert; Fraser, Scott E., Hybridization chain reaction amplification for in situ imaging.
  109. Davis Thomas A. (Chantilly VA) Kessler Steven (Cupertino CA) Robinson Douglas H. (Washington DC), In vitro amplification/expansion of CD34+stem and progenitor cells.
  110. Anderson David J. ; Stemple Derek L., In vitro method for obtaining an isolated population of mammalian neural crest stem cells.
  111. Bender James G. ; Maples Phillip B. ; Smith Stephen ; Unverzagt Kristen L. ; Van Epps Dennis E., In vitro-derived genetically altered human neutrophil precursor cells and methods for administering the same.
  112. Scadden David T. ; Freedman Andrew,GBX, In-vitro T-lymphopoiesis system.
  113. Bender James G. ; Maples Phillip B. ; Smith Stephen L. ; Unverzagt Kristen L. ; Van Epps Dennis E., In-vitro-derived human neutrophil precursor cells.
  114. Burger Scott Robert ; Hubel Allison ; McCullough John Jeffrey, Infusible grade short-term cell storage medium.
  115. Burger Scott Robert ; Hubel Allison ; McCullough John Jeffrey, Infusible grade short-term cell storage medium for mononuclear cells.
  116. Chen, Yiyou; Chen, Dan; Day, Anthony G.; Estell, David A.; Geng, Wei, Isolating human antibodies.
  117. Clarke, Michael F.; Morrison, Sean J.; Wicha, Max S.; Al-Hajj, Muhammad, Isolation and use of solid tumor stem cells.
  118. Clarke, Michael F.; Morrison, Sean J.; Wicha, Max S.; Al-Hajj, Muhammad, Isolation and use of solid tumor stem cells.
  119. Clarke, Michael F.; Morrison, Sean J.; Wicha, Max S.; Al-Hajj, Muhammad, Isolation and use of solid tumor stem cells.
  120. Clarke,Michael F.; Morrison,Sean J.; Wicha,Max S.; Al Hajj,Muhammad, Isolation and use of solid tumor stem cells.
  121. Clarke,Michael F.; Morrison,Sean J.; Wicha,Max S.; al Hajj,Muhammad, Isolation and use of solid tumor stem cells.
  122. Vacanti,Charles A.; Vacanti,Martin P., Isolation of spore-like cells from tissues exposed to extreme conditions.
  123. Lyman,Stewart D.; Beckmann,M. Patricia, Ligands for flt3 receptors.
  124. Verfaillie, Catherine M.; Gallegos, Robert; Jerosch-Herold, Michael, MAPC generation of muscle.
  125. Gurney, Austin L.; Xie, Ming-Hong; Bond, Christopher John, MET-binding agents and uses thereof.
  126. Palsson, Bernhard O.; Armstrong, R. Douglas; Clarke, Michael F.; Emerson, Stephen G., METHODS FOR REGULATING THE SPECIFIC LINEAGES OF CELLS PRODUCED IN A HUMAN HEMATOPOIETIC CELL CULTURE, METHODS FOR ASSAYING THE EFFECT OF SUBSTANCES ON LINEAGE-SPECIFIC CELL PRODUCTION, AND CELL COMPO.
  127. Wang Yuzhou ; Tang Weixin ; Liberti Paul A., Magnetic separation apparatus.
  128. Anderson David J. ; Stemple Derek L., Mammalian multipotent neural stem cells.
  129. Anderson David J. ; Stemple Derek L., Mammalian multipotent neural stem cells.
  130. Xu, Ruiling; Liebmann-Vinson, Andrea; DeLuca, Keith; Heidaran, Mohammad, Material and methods for the growth of hematopoietic stem cells.
  131. Lyman, Stewart D.; Beckmann, M. Patricia, Medium containing flt3 ligand for culturing hematophoietic cells.
  132. Varner, Judith A., Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration.
  133. Brown Ronald L., Method for culturing CD34.sup.+ cells in a serum-free medium.
  134. Keller, Gordon M.; Hawley, Robert G.; Choi, Kyunghee, Method for identification of cell growth or differentiation factors.
  135. Bender James G. ; Maples Phillip B. ; Smith Stephen ; Unverzagt Kristen L. ; Van Epps Dennis E., Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells.
  136. Lemischka, Ihor R., Method for isolating cells expressing flk-2.
  137. Lemischka Ihor R., Method for isolating stem cells expressing flk-1 receptors.
  138. Schwartz Richard M. ; Elkalay Mohammed A., Method for mammalian cell separation from a mixture of cell populations.
  139. Rigg Richard J. ; Chen Jingyi ; Dando Jonathan S. ; Plavec Ivan ; Forestell Sean P. ; Bohnlein Ernst, Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant.
  140. Rigg Richard J. ; Chen Jingyi ; Dando Jonathan S.,ITX ; Plavec Ivan ; Forestell Sean P. ; Bohnlein Ernst, Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant.
  141. Brown Ronald L., Method for repopulating human bone marrow comprising culturing CD34+ cells in a serum free medium.
  142. Ronald L. Brown, Method for repopulating human bone marrow comprising culturing CD34+ cells in a serum free medium.
  143. Shroff, Geeta, Method for storing a preparation of human embryonic stem cells.
  144. Ramiya,Vijaykumar; Clark,Amy, Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway.
  145. Clarke, Michael F.; Wicha, Max S.; Al-Hajj, Muhammad, Method for treating cancer using a Notch4 ligand antagonist.
  146. Clarke, Michael F.; Wicha, Max S.; Al-Hajj, Muhammad, Method for treating cancer using an antibody that inhibits notch4 signaling.
  147. Vacanti, Joseph P.; Rubin, Robert; Cheung, Wing; Borenstein, Jeffrey T., Method of determining metabolism of a test agent.
  148. Schwartz Richard Merrill ; Tucker Sean Newton ; Chary Srikanth Ranga ; Kuo Suzanne Chang, Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein.
  149. Galy Anne H. M., Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation.
  150. Itescu, Silviu, Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue.
  151. Itescu, Silviu, Method of inhibiting collagen formation by VDUP1 inhibition.
  152. Pang Kevin K. ; Homa Monica W., Method of isolating bile duct progenitor cells.
  153. Shroff, Geeta, Method of isolating human embryonic stem cells in minimal essential medium.
  154. Shroff, Geeta, Method of partially differentiating hES cells.
  155. Abuljadayel, Ilham Saleh, Method of preparing an undifferentiated cell.
  156. Galy Anne H. M., Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells ob.
  157. Broudy Virginia C. ; Lin Nancy, Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor.
  158. Galy Anne H. M., Method of reconstituting human lymphoid and dendritic cells.
  159. Scadden David T., Method of screening a compound for hematopoietic activity.
  160. Rosenthal Gary J. (Boulder CO) Gerber Michael J. (Denver CO), Method of stimulating hematopoiesis with hemoglobin.
  161. Conboy, Irina M.; Conboy, Michael J.; Yousef, Hanadie; Schaffer, David V., Methods and compositions for somatic cell proliferation and viability.
  162. Conboy, Irina M.; Conboy, Michael J.; Yousef, Hanadie; Schaffer, David V., Methods and compositions for somatic cell proliferation and viability.
  163. Essner, Jeffrey J.; Liao, Hsin-Kai; Fahrenkrug, Scott C., Methods and compositions for targeted gene modification.
  164. Pykett,Mark J.; Rosenzweig,Michael; Kaplan,Richard B., Methods and devices for the long-term culture of hematopoietic progenitor cells.
  165. Dupont, Jakob; Stagg, Robert J., Methods and monitoring of treatment with a WNT pathway inhibitor.
  166. Dupont, Jakob; Stagg, Robert J., Methods and monitoring of treatment with a Wnt pathway inhibitor.
  167. Eugene Mechetner ; John Fruehauf, Methods and reagents for preparing and using immunological agents specific for P-glycoprotein.
  168. Mechetner Eugene ; Roninson Igor B., Methods and reagents for preparing and using immunological agents specific for P-glycoprotein.
  169. Mechetner, Eugene; Roninson, Igor B., Methods and reagents for preparing and using immunological agents specific for P-glycoprotein.
  170. Mechetner,Eugene; Fruehauf,John, Methods and reagents for preparing and using immunological agents specific for P-glycoprotein.
  171. Sherwood, Steven W., Methods for detecting targets.
  172. Anderson David J., Methods for differentiating neural stem cells to glial cells using neuregulins.
  173. Anderson David J. ; Shah Nirao M., Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-.beta. super family growth factors.
  174. Uchida Nobuko ; Tsukamoto Ann ; Weissman Irving, Methods for gene transfer.
  175. Jones Richard J. ; Colvin O. Michael ; Hilton John ; Sharkis Saul, Methods for identification or purification of cells containing an enzymatic intracellular marker.
  176. Wong, Chi-Huey; Wu, Chung-Yi, Methods for modifying human antibodies by glycan engineering.
  177. Vilen, Barbara J.; Kilmon, Michelle; Rutan, Jennifer A., Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor.
  178. Janssen,Giselle G.; Murray,Christopher J.; Winetzky,Deborah S., Methods for selective targeting.
  179. Murray, Christopher J.; Tijerina, Pilar; Estell, David A.; Chen, Yiyou, Methods for selective targeting.
  180. Murray,Lesley J; Young,Judy C, Methods for use of MPL ligands with primitive human stem cells.
  181. Murray Lesley J. ; Young Judy C., Methods for use of Mpl ligands with primitive human stem cells.
  182. Murray, Lesley J.; Young, Judy C., Methods for use of mpl ligands with primitive human stem cells.
  183. Shroff, Geeta, Methods of expanding human embryonic stem cells.
  184. Reid,Lola M.; Sigal,Samuel H.; Brill,Shlomo; Holst,Patricia A., Methods of isolating hepatic progenitors.
  185. Hill Beth Louise ; Rozler Elen ; Chen Benjamin P., Methods of obtaining compositions enriched for hematopoietic stem cells, antibodies for use therein, compositions derived therefrom and methods of use thereof.
  186. Simmons Paul J. (Adelaide AUX) Hill Beth L. (Mountain View CA) Chen Benjamin P. (Fremont CA), Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of u.
  187. Lynch,David H.; Brasel,Kenneth A.; McKenna,Hilary J.; Borges,Luis G.; Maliszewski,Charles R.; Maraskovsky,Eugene, Methods of preparing dendritic cells with flt3-ligand and antigen.
  188. Gurney, Austin; Lewicki, John; Satyal, Sanjeev H.; Hoey, Timothy, Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor.
  189. Stagg, Robert Joseph; Dupont, Jakob, Methods of treating neuroendocrine tumors using frizzled-binding agents.
  190. Gurney, Austin L.; Sato, Aaron Ken; Axelrod, Fumiko Takada; Hoey, Timothy Charles; Satyal, Sanjeev H.; Mitra, Satyajit Sujit Kumar, Methods of use for an antibody against human frizzled receptors 1, 2. 5, 7 or 8.
  191. Lyman Stewart D. ; Beckmann M. Patricia, Methods of using Flt-3 ligand for exogenous gene transfer.
  192. Lyman,Stewart D.; Beckmann,M. Patricia, Methods of using flt3-ligand in hematopoietic cell transplantation.
  193. Lynch,David H.; Borges,Luis; Miller,Robert E.; Maliszewski,Charles R., Methods of using flt3-ligand in the treatment of fibrosarcoma.
  194. Gurney, Austin; Lewicki, John; Satyal, Sanjeev; Hoey, Timothy, Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell.
  195. Palsson Bernhard O. ; Emerson Stephen G. ; Schwartz Richard M., Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells.
  196. Vacanti, Joseph P.; Borenstein, Jeffrey T.; Weinberg, Eli, Microfabricated compositions and processes for engineering tissues containing multiple cell types.
  197. Borenstein, Jeffrey T.; Weinberg, Eli; Orrick, Brian K.; Pritchard, Eleanor M.; Barnard, Edward J.; Krebs, Nicholas J.; Marentis, Theodore; Vacanti, Joseph P.; Kaazempur-Mofrad, Mohammad Reza, Micromachined bilayer unit for filtration of small molecules.
  198. Borenstein, Jeffrey T.; Weinberg, Eli; Orrick, Brian K.; Pritchard, Eleanor M.; Barnard, Edward J.; Krebs, Nicholas J.; Marentis, Theodore; Vacanti, Joseph P.; Kaazempur-Mofrad, Mohammad Reza, Micromachined bilayer unit of engineered tissues.
  199. Glaser,Lawrence F., Modified erythrocytes and uses thereof.
  200. Gurney, Austin L.; Sato, Aaron Ken; Axelrod, Fumiko Takada; Hoey, Timothy Charles; Satyal, Sanjeev H.; Mitra, Satyajit Sujit Kumar, Monoclonal antibodies against frizzled.
  201. Ohara,Takaaki; Yamashita,Kenji; Kakutani,Tetsu; Kyoizumi,Seishi, Monoclonal antibody, its immunoreactive fragment and hybridoma.
  202. Kuberasampath Thangavel ; Rueger David C. ; Oppermann Hermann ; Pang Roy H. L. ; Cohen Charles M., Morphogen-induced liver regeneration.
  203. Borenstein,Jeffrey T.; King,Kevin R.; Terai,Hidetomi; Vacanti,Joseph P., Multilayer device for tissue engineering.
  204. Furcht,Leo T.; Verfaillie,Catherine M.; Reyes,Morayma, Multiponent adult stem cells and methods for isolation.
  205. Furcht, Leo T.; Verfaillie, Catherine M.; Reyes, Morayma, Multipotent adult stem cells.
  206. Furcht, Leo T.; Verfaillie, Catherine M.; Reyes, Morayma, Multipotent adult stem cells and methods for isolation.
  207. Haas, Martin, Multipotent amniotic fetal stem cells.
  208. Crawford, Keith D.; Southgate, Chris, Multipotent stem cells and uses thereof.
  209. Crawford, Keith D.; Southgate, Christopher, Multipotent stem cells and uses thereof.
  210. Anderson David J. (Altadena CA) Stemple Derek L. (Newton MA), Neural chest stem cell assay.
  211. Gurney, Austin; Lewicki, John; Satyal, Sanjeev; Hoey, Timothy, Nucleic acid molecules encoding soluble frizzled (FZD) receptors.
  212. Gallo, Robert C.; Bryant, Joseph; Lunardi-Iskandar, Yanto, Nucleic acids encoding biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA).
  213. Dirks, Robert; Pierce, Niles A., PKR activation via hybridization chain reaction.
  214. Scadden, David T.; Calvi, Laura M.; Adams, Gregor; Kronenberg, Henry M., Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion.
  215. Scadden,David T.; Calvi,Laura M.; Adams,Gregor; Kronenberg,Henry, Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion.
  216. Scadden, David T.; Calvi, Laura M.; Adams, Gregor; Kronenberg, Henry, Parathyroid hormone receptor activation and stem and progenitor cell expansion.
  217. Scadden, David T.; Calvi, Laura M.; Adams, Gregor; Kronenberg, Henry M., Parathyroid hormone receptor activation and stem and progenitor cell expansion.
  218. Papayannopoulou Thalia, Peripheralization of hematopoietic stem cells.
  219. Papayannopoulou, Thalia, Peripheralization of hematopoietic stem cells.
  220. Gurney, Austin L.; Sato, Aaron Ken; Axelrod, Fumiko Takada; Hoey, Timothy Charles; Satyal, Sanjeev H.; Mitra, Satyajit Sujit Kumar, Polynucleotides encoding for frizzled-binding agents and uses thereof.
  221. Lemischka,Ihor R., Populations of cells that express FLK-1 receptors.
  222. Lemischka,Ihor R., Populations of cells that express flk-2 receptors.
  223. Thomson, James A., Preparation of human embryonic stem cells.
  224. Thomson, James A., Primate embryonic stem cell line.
  225. Thomson James A., Primate embryonic stem cells.
  226. Reid Lola M. ; Agelli Maria, Proliferation of hepatocyte precursors.
  227. Reid, Lola M.; Agelli, Maria; Ochs, Andreas, Proliferation of hepatocyte precursors.
  228. Chaudhary Preet M. ; Roninson Igor B., Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression.
  229. Rafii, Shahin; Witte, Larry; Moore, Malcolm A. S., Purified populations of stem cells.
  230. Wong, Chi-Huey; Wu, Chung-Yi; Chuang, Hong-Yang; Ren, Chien-Tai, RM2 antigens and use thereof.
  231. Wong, Chi-Huey; Fang, Jim-Min; Shie, Jiun-Jie, Reactive labelling compounds and uses thereof.
  232. Itescu, Silviu, Regeneration of endogenous myocardial tissue.
  233. Pippig, Susanne Dagmar; Veres, Gabor, Selectable cell surface marker genes.
  234. Kraus Morey ; Wilder Paul T. ; Friberg Jill, Selective expansion of target cell populations.
  235. Morey Kraus ; Paul T. Wilder ; Jill Friberg, Selective expansion of target cell populations.
  236. Yin, Peng, Self-assembled polynucleotide structure.
  237. Peled, Tony; Fibach, Eitan; Rachmilewitz, Eliezer A., Serum-derived factor inducing cell differentiation and medical uses thereof.
  238. Pierce, Niles A.; Hochrein, Lisa, Small conditional RNAs.
  239. Lemischka, Ihor R., Soluble human flk-2 protein.
  240. Gerber Michael J. ; Looker Douglas L. ; Kerwin Bruce A., Stabilized compositions containing hemoglobin.
  241. Gentry, Tracy; Foster, Sandra J.; Balber, Andrew E., Stem cell populations and methods of use.
  242. Gentry, Tracy; Foster, Sandra J.; Balber, Andrew E., Stem cell populations and methods of use.
  243. Beschorner William E., Surrogate tolerogenesis for the development of tolerance to xenografts.
  244. Wolf ; Jr. Ludwig, Systems for processing and storing placenta/umbilical cord blood.
  245. Weksler Marc E. (Tenafly NJ) Szabo Paul (Linden NJ), T cell factors influencing B cell development.
  246. Nishimura Michael ; Rosenberg Steven A., T-cell receptors and their use in therapeutic and diagnostic methods.
  247. Gregory, Philip D.; Holmes, Michael C.; Rebar, Edward J.; Urnov, Fyodor, Targeted integration and expression on exogenous nucleic acid sequences.
  248. Itescu, Silviu, Treatment of tumor with dnazyme directed to peroxiredoxin.
  249. Pierce, Niles A.; Yin, Peng, Triggered RNAi.
  250. Pierce, Niles A.; Yin, Peng, Triggered RNAi.
  251. Yin, Peng; Pierce, Niles A., Triggered RNAi.
  252. Pierce, Niles A.; Vieregg, Jeffrey Robert, Triggered covalent probes for imaging and silencing genetic expression.
  253. Yin, Peng; Pierce, Niles A., Triggered molecular geometry based bioimaging probes.
  254. Itescu, Silviu, Use of SDF-1 or G-CSF to improve myocardial function after ischemic injury.
  255. Itescu, Silviu, Use of SDF-1 to improve ischemic myocardial function.
  256. Itescu, Silviu, Use of SDF-1 to improve ischemic myocardial function.
  257. Gammelsaeter, Runhild; Remmereit, Jan, Use of cellular extracts for skin rejuvenation.
  258. Gammelsaeter, Runhild; Remmereit, Jan, Use of cellular extracts for skin rejuvenation.
  259. Gammelsaeter, Runhild; Remmereit, Jan, Use of cellular extracts for skin rejuvenation.
  260. Gammelsaeter, Runhild; Remmereit, Jan, Use of cellular extracts for skin rejuvenation.
  261. Uchida Nobuko, Use of collagenase in the preparation of neural stem cell cultures.
  262. Uchida,Nobuko, Use of collagenase in the preparation of neural stem cell cultures.
  263. Nakahata Tatsutoshi (Tokyo JPX), Use of stem cell factor interleukin-6 and soluble interleukin-6 receptor to induce the development of hematopoietic stem.
  264. Yin, Peng; Pierce, Niles A., Versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways.
  265. Satyal, Sanjeev H.; Mitra, Satyajit Sujit Kumar; Gurney, Austin L., Wnt antagonist and methods of treatment and screening.
  266. Satyal, Sanjeev H.; Mitra, Satyajit Sujit Kumar; Gurney, Austin L., Wnt antagonists and methods of treatment and screening.
  267. Wagner Thomas E. ; Antczak Michael R., Yolk sac stem cells and their uses.
  268. Gregory, Philip D.; Miller, Jeffrey C., Zinc finger proteins and method for inactivating a dhfr gene in a chinese hamster ovary cell.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로